Tillotts Pharma and TVM Capital Form Mage Biologics to Develop Oral Antibody Therapy for Ulcerative Colitis

Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to ensure optimal and local trea...

July 21, 2023 | Friday | News
PromoCell Launches PromoExQ MSC Growth Medium XF for GMP-Compliant MSC Expansion

PromoExQ MSC Growth Medium XF enables the long-term expansion of a variety of MSC types, including MSCs from the bone marrow, umbilical cord matrix, and ad...

July 21, 2023 | Friday | News
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States call...

July 21, 2023 | Friday | News
Bio-Rad Announces New Share Repurchase Program

“The new share buyback authorization is consistent with our disciplined approach and demonstrates our continued commitment to using this tool as part...

July 21, 2023 | Friday | News
Integrated Biosciences Unveils Synthetic Biology Platform for Aging-Associated Stress Response Control

Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...

July 20, 2023 | Thursday | News
AES Clean Technology achieves LEED certification for its cleanroom architectural system

LEED is a globally recognized symbol of sustainability achievement and leadership, and is a key milestone for AES, enabling it to meet increased customer d...

July 20, 2023 | Thursday | News
Neumora Therapeutics Begins Phase 3 Program for NMRA-140 in Major Depressive Disorder

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned init...

July 19, 2023 | Wednesday | News
Massive Bio and CureMatch Partner to Revolutionize Cancer Treatment with AI and Clinical Trial Accessibility.

Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representa...

July 19, 2023 | Wednesday | News
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon p...

July 19, 2023 | Wednesday | News
HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia&...

July 19, 2023 | Wednesday | News
QIAGEN expands range of digital PCR kits and services for the biopharma industry

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the expansion of its digital PCR (dPCR) offering for the development of cell and gene th...

July 19, 2023 | Wednesday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Eleven Therapeutics Collaborates with Novo Nordisk for Nucleic Acid Therapeutics Discovery

 Through this collaboration, the companies aim to identify novel molecules that promote precise delivery of nucleic acid by leveraging Eleven's innova...

July 18, 2023 | Tuesday | News
DTx Pharma announces acquisition by Novartis

DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics Acquisition ...

July 18, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close